“I’m excited to launch the tablet as a result of I’ve acknowledged that so many individuals proper now are in want of weight reduction however are nonetheless not going ahead with [medications like Wegovy] as a result of there’s a taboo with injections,” Novo Nordisk’s CEO Mike Doustdar tells TIME. “They need to swallow a tablet with out being judged if somebody sees them injecting [a medication]. We waited and waited to guarantee that when the tablet comes out, it’s the fitting one and probably the most efficacious one.”
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
